<DOC>
	<DOCNO>NCT02724735</DOCNO>
	<brief_summary>All subject complete randomized treatment period Protocol NS2014-1 discontinue study drug ask provide consent follow 6-month study , final safety visit . The study consist enrollment visit , follow bi-monthly in-clinic visit monthly telephone visit in-clinic visit .</brief_summary>
	<brief_title>A Longitudinal Observational Cohort Study NSI-189 , With Out-Patients With Major Depressive Disorder</brief_title>
	<detailed_description>Following completion NS2014-1 final study visit procedure , Subjects offer opportunity enroll longitudinal observational cohort protocol monitor depression ass durability effect long-term safety NSI-189 . The Enrollment Visit begin informed consent signed.The duration follow-up period 6 month , start new antidepressant treatment . Subjects provide consent see in-person visit every 8 week , bi-monthly phone visit occur in-person visit . Safety assessment efficacy assessment perform visit . No study drug take Longitudinal Observational Cohort study .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<criteria>1 . Subject ability understand purpose , potential benefit risk study provide sign date informed consent , authorize use protect health information accordance national local Subject privacy regulation . 2 . Subject complete 12week randomized treatment period final study visit NS20141 clinical study . 1 . Subjects take excluded medication . 2 . Subject , opinion Site Investigator , unable understand protocol requirement , instruction studyrelated restriction , nature , scope possible consequence clinical study . 3 . Subject , opinion Site Investigator , unlikely comply protocol requirement , instruction studyrelated restriction ; e.g. , uncooperative attitude , inability return followup improbability complete clinical study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>61 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Depression</keyword>
	<keyword>Major Depressive Disorder ( MDD )</keyword>
	<keyword>Major Depressive Disorder</keyword>
	<keyword>Neurogenesis</keyword>
	<keyword>Synaptogenesis</keyword>
	<keyword>NSI-189</keyword>
	<keyword>Neuralstem</keyword>
</DOC>